Equities Research Analysts’ updated eps estimates for Tuesday, August 8th:

Agios Pharmaceuticals (NASDAQ:AGIO) was given a $90.00 price target by analysts at Canaccord Genuity. The firm currently has a buy rating on the stock.

Allison Transmission Holdings (NASDAQ:ALSN) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $48.00 price target on the stock, up from their previous price target of $46.00.

BioLineRx (NASDAQ:BLRX) was given a $3.00 price target by analysts at Maxim Group. The firm currently has a buy rating on the stock.

Colliers International Group (NASDAQ:CIGI) (TSE:CIGI) had its outperform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $62.00 target price on the stock, up from their previous target price of $58.00.

Cummins (NYSE:CMI) had its hold rating reissued by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $168.00 target price on the stock, up from their previous target price of $160.00.

Coherent (NASDAQ:COHR) had its buy rating reissued by analysts at Benchmark Co.. The firm currently has a $290.00 price target on the stock, down from their previous price target of $295.00.

Cathay Pacific Airways (OTCMKTS:CPCAY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CATHAY PACIFIC AIRWAY’s principal activity is the operation of an international airline based and registered in Hong Kong. Other activities include airline catering, aircraft handling and engineering. The Group offers scheduled passenger and cargo services to 62 destinations around the world. It operates in Hong Kong, Mainland China, Japan, Korea, Taiwan, South East Asia, Middle East, Europe, Pacific and South Africa. “

Computer Programs and Systems (NASDAQ:CPSI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $36.00 target price on the stock. According to Zacks, “Computer Programs and Systems, Inc has been serving the information technology needs of community healthcare providers for over twenty-seven years. Headquartered in Mobile, Alabama, the company provides a complete health information and patient care system that encompasses the full spectrum of financial and clinical applications. The CPSI System provides the most comprehensive single-source electronic medical record available and allows the realization of a true enterprise-wide electronic medical record. The Company is a single-source vendor providing comprehensive software and hardware products, complemented by complete installation services and extensive support. Its fully integrated, enterprise-wide system automates clinical and financial data management in each of the primary functional areas of a hospital. “

CSG Systems International (NASDAQ:CSGS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CSG Systems International Inc. is a leading provider of outsourced billing, customer care and print and mail solutions and services supporting the North American cable and direct broadcast satellite markets. CSG’s solutions support some of the world’s largest and most innovative providers of bundled multi-channel video, Internet, voice and IP-based services. CSG’s unique combination of solutions, services and expertise ensure that cable and satellite operators can continue to rapidly launch new service offerings, improve operational efficiencies and deliver a high-quality customer experience in a competitive and ever-changing marketplace. “

Capital Senior Living Corporation (NYSE:CSU) had its hold rating reiterated by analysts at Stifel Nicolaus. They currently have a $15.00 target price on the stock, up from their previous target price of $13.00.

Ducommun (NYSE:DCO) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Ducommun Incorporated manufactures components and assemblies principally for domestic and foreign commercial and military aircraft and space programs. Ducommun is a subcontractor to Lockheed Martin on the Space Shuttle external tank and a supplier of components for the Space Shuttle, as well as for the International Space Station. “

DCP Midstream Partners, (NYSE:DCP) had its sector perform rating reissued by analysts at Royal Bank Of Canada. They currently have a $37.00 target price on the stock, down from their previous target price of $40.00.

Denny’s Corporation (NASDAQ:DENN) had its outperform rating reiterated by analysts at Wedbush.

Physicians Realty Trust (NYSE:DOC) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Physicians Realty Trust is a REIT. It is a self-managed healthcare real estate company engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company’s principal investments will include medical office buildings, outpatient treatment facilities, acute and post-acute care hospitals, as well as other real estate integral to healthcare providers. Physicians Realty Trust is based in Milwaukee, Wisconsin. “

Detour Gold Corpor (OTCMKTS:DRGDF) was upgraded by analysts at Credit Suisse Group from a neutral rating to an outperform rating.

Campari Group (OTCMKTS:DVDCY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Davide Campari Milano SpA is engaged in the beverage industry, which has spirits, wines and soft drinks segments. It products includes Aperol, Appleton Estate, Campari, SKYY, Wild Turkey and Grand Marnier. Davide Campari Milano SpA headquartered in Milan, Italy. “

DexCom (NASDAQ:DXCM) had its outperform rating reiterated by analysts at BMO Capital Markets. They currently have a $90.00 target price on the stock, down from their previous target price of $105.00.

Erste Group Bank AG (OTCMKTS:EBKDY) was upgraded by analysts at Zacks Investment Research from a sell rating to a strong-buy rating. They currently have $25.00 target price on the stock. According to Zacks, “The Erste Bank der Muster is a traditional banking group and providering financial services in Central and Eastern Europe. It focuses on retail and SME banking. It offers a range of products through group-wide bundling of product know how into Competence Centres covering, among others, Debt financing, Equity capital markets ,Mergers and acquisitions,Debt advisory, Project financing, Syndication, Real Estate financing and solutions, Infrastructure Finance & Public Sector, Merchant Banking / Private Equity, Leasing solutions (IMMORENT), and Corporate Cash Management. Its customers can avail its products in netbanking, wether it is Komfort-Kredit, Profit account, Bonus account, Building society contract, Pension plan or the order of MasterCard or VISA Card. Erste Bank focuses on private clients, corporate clients and the public sector. it offers all financial products under one roof. It operates in the areas of investment , construction and living , and leasing. Erste Bank is based in Vienna, Austria. “

Eiger BioPharmaceuticals (NASDAQ:EIGR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Eiger BioPharmaceuticals, Inc. is a biopharmaceutical company which develops and manufactures drugs and therapies for the treatment of orphan diseases. Eiger BioPharmaceuticals, Inc., formerly known as Celladon Corporation, is based in Palo Alto, California. “

E.On Se (NASDAQ:EONGY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “E.ON AG is the world’s largest investor-owned energy service provider with operations in the following businesses: energy, chemicals, real estate, oil, telecommunications, distribution/logistics, aluminum and silicon wafers. “

Eaton Vance Corporation (NYSE:EV) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Eaton Vance Corp.’s principal business is creating, marketing and managing investment funds and providing investment management and counseling services to institutions and individuals.The Company conducts its investment management and counseling business through two wholly-owned subsidiaries, Eaton Vance Management and Boston Management and Research.The Company’s growth has resulted from its ability to develop, offer successfully and manage effectively new funds and to increase the assets of existing Eaton Vance Funds. “

FBL Financial Group (NYSE:FFG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $78.00 target price on the stock. According to Zacks, “FBL FINANCIAL GROUP, INC. is a holding company and hrough its subsidiaries underwrites, markets and distributes life insurance, annuities, property-casualty insurance and mutual funds to individuals and small businesses in 15 midwestern and western states. The Company has exclusive marketing arrangements with the state Farm Bureau Federations in its territory and targets sales to approximately 700,000 Farm Bureau member families and other rural, small town andsuburban residents through an exclusive agency force. The Company offers a full range of life insurance products. “

Fortress Investment Group (NYSE:FIG) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “FORTRESS INVESTMENT Group is a leading global alternative asset manager with approximately $34.2 billion in assets under management as of March 31, 2008. Fortress is headquartered in New York and has affiliates with offices in Chicago, Dallas, Frankfurt, Geneva, Hong Kong, London, Los Angeles, Munich, New Canaan, Rome, San Francisco, San Diego, Sydney, Tokyo and Toronto.Fortress raises, invests and manages private equity funds and hedge funds. Fortress intends to grow its existing businesses, while continuing to create innovative products to meet the increasing demand by sophisticated investors for superior risk-adjusted investment returns. “

Fiserv (NASDAQ:FISV) had its sector perform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $128.00 price target on the stock, up from their previous price target of $123.00.

FleetCor Technologies (NYSE:FLT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $160.00 target price on the stock. According to Zacks, “FleetCor is a leading independent global provider of fuel cards, commercial payment and data solutions, lodging and transportation management services, stored value solutions, and workforce payment products and services to businesses, retailers, commercial fleets, major oil companies, petroleum marketers and government entities in countries throughout North America, Latin America, Europe, Australia and New Zealand. They also provide a suite of fleet related and workforce payment solution products, including mobile telematics services, fleet maintenance management and employee benefit and transportation related payments. “

First Mid-Illinois Bancshares (NASDAQ:FMBH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $40.00 target price on the stock. According to Zacks, “First Mid-Illinois Bancshares, Inc. is a financial holding company. The Company is engaged in the business of banking through its wholly owned subsidiary, First Mid-Illinois Bank & Trust, N.A. It operates in three lines of business: community banking and wealth management through First Mid Bank, and insurance brokerage through First Mid Insurance Group. The company’s deposit products include demand, savings, money market, and time deposits, as well as NOW accounts. Its loan portfolio primarily comprise commercial real estate, commercial and industrial, agricultural and agricultural real estate, residential real estate, and consumer loans. The company also offers estate planning, investment, and farm management services; and employee benefit services. In addition, it provides commercial lines insurance to businesses; and homeowner, automobile, and other types of personal lines insurance to individuals. First Mid-Illinois Bancshares, Inc is headquartered in Mattoon, Illinois. “

Hannon Armstrong Sustainable Infrastructure Capital (NYSE:HASI) had its buy rating reiterated by analysts at Oppenheimer Holdings, Inc..

Hikma Pharmaceuticals Plc (OTC:HKMPF) had its equal weight rating reaffirmed by analysts at Morgan Stanley.

Hennes & Mauritz AB (OTCMKTS:HNNMY) had its neutral rating reiterated by analysts at Goldman Sachs Group, Inc. (The).

Intercept Pharmaceuticals (NASDAQ:ICPT) had its underweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $69.00 target price on the stock, up from their previous target price of $60.00. The analysts wrote, “In AESOP, OCA-treated PSC patients demonstrated significant decrease from baseline in alkaline phosphatase (ALP) of -22% compared with placebo-treated patients’ increase of +1% at 24 weeks,” the firm said.”Additionally, CONTROL demonstrated atorvastatin’s ability to reduce elevations of LDL-C in OCA-treated patients by 40-48mg/dL.”

InterXion Holding N.V. (NYSE:INXN) was upgraded by analysts at Cowen and Company to an outperform rating. The analysts wrote, “Quarterly results were solid and we believe the company is well positioned to continue to capitalize on the strong secular tailwinds in the data center sector that we anticipate should continue to drive our PT higher,”

Michael Kors Holdings Limited (NYSE:KORS) was given a $46.00 target price by analysts at Piper Jaffray Companies. The firm currently has a hold rating on the stock.

Leju Holdings Limited (NYSE:LEJU) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

Lumber Liquidators Holdings (NYSE:LL) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $35.00 target price on the stock, up from their previous target price of $27.00.

Mimecast Limited (NASDAQ:MIME) had its outperform rating reiterated by analysts at Oppenheimer Holdings, Inc.. They currently have a $32.00 price target on the stock, up from their previous price target of $27.00.

Man Group Plc (NASDAQ:MNGPF) had its neutral rating reaffirmed by analysts at Citigroup Inc..

Mallinckrodt PLC (NYSE:MNK) was given a $70.00 price target by analysts at Oppenheimer Holdings, Inc.. The firm currently has a buy rating on the stock.

Mosaic Company (The) (NYSE:MOS) had its sector perform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $23.00 target price on the stock, down from their previous target price of $25.00.

WM Morrison Supermarkets PLC (NASDAQ:MRWSY) had its hold rating reaffirmed by analysts at HSBC Holdings plc.

Paycom Software (NYSE:PAYC) had its sector perform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $74.00 target price on the stock, up from their previous target price of $67.00.

Pitney Bowes (NYSE:PBI) was downgraded by analysts at Cross Research from a hold rating to a sell rating.

Royal Caribbean Cruises (NYSE:RCL) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $129.00 target price on the stock, up from their previous target price of $125.00.

Regeneron Pharmaceuticals (NASDAQ:REGN) was downgraded by analysts at Robert W. Baird from a neutral rating to an underperform rating. Robert W. Baird currently has $408.00 target price on the stock. The analysts wrote, “nothing to scoff at,” Skorney said in his downgrade note. However, investor expectations for a strong performance has “stretched the valuation beyond what is reasonable” based on the initial launch metrics (see Skorney’s track record here).In fact, investor expectation shifted from “high” in late April/May to “extraordinary” today, the analyst added. Meanwhile, buy-side analysts may have also gotten ahead of themselves in predicting Dupixent to outperform Novartis’ blockbuster therapy, Cosentyx.”We believe shares reflect a greater degree of optimism than is warranted,” Skorney emphasized. “We continue to believe Dupixent will be a big drug, as reflected by our reiterated target price of $408.”

ResMed (NYSE:RMD) was downgraded by analysts at Credit Suisse Group from an outperform rating to a neutral rating.

Ross Stores (NASDAQ:ROST) had its neutral rating reissued by analysts at Credit Suisse Group. Credit Suisse Group currently has a $64.00 target price on the stock, down from their previous target price of $70.00.

RadiSys Corporation (NASDAQ:RSYS) had its buy rating reissued by analysts at Lake Street Capital. Lake Street Capital currently has a $3.00 price target on the stock, down from their previous price target of $4.50.

RadiSys Corporation (NASDAQ:RSYS) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $2.50 target price on the stock, down from their previous target price of $4.50.

Steven Madden (NASDAQ:SHOO) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $45.00 target price on the stock, up from their previous target price of $41.00.

Shopify (NYSE:SHOP) (TSE:SH) had its sector perform rating reissued by analysts at Royal Bank Of Canada. They currently have a $99.00 target price on the stock, up from their previous target price of $78.00.

Shopify (NYSE:SHOP) (TSE:SH) had its outperform rating reiterated by analysts at Wedbush. They currently have a $115.00 price target on the stock, up from their previous price target of $100.00.

Sientra (NASDAQ:SIEN) had its buy rating reiterated by analysts at Lake Street Capital. Lake Street Capital currently has a $15.00 target price on the stock, up from their previous target price of $11.00.

Silicon Motion Technology Corp. (NASDAQ:SIMO) had its buy rating reaffirmed by analysts at Lake Street Capital. Lake Street Capital currently has a $50.00 target price on the stock, down from their previous target price of $56.00.

J P Morgan Chase & Co started coverage on shares of Southern Company (The) (NYSE:SO). They issued an overweight rating and a $16.78 target price on the stock.

SPS Commerce (NASDAQ:SPSC) had its buy rating reaffirmed by analysts at Oppenheimer Holdings, Inc..

TJX Companies, Inc. (The) (NYSE:TJX) had its neutral rating reissued by analysts at Credit Suisse Group. They currently have a $72.00 price target on the stock, down from their previous price target of $79.00.

Under Armour (NYSE:UAA) had its neutral rating reissued by analysts at Wedbush. Wedbush currently has a $17.00 target price on the stock, down from their previous target price of $18.00.

Under Armour (NYSE:UAA) had its market perform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $18.00 price target on the stock, down from their previous price target of $21.00.

Under Armour (NYSE:UAA) had its hold rating reaffirmed by analysts at Canaccord Genuity. The firm currently has a $18.00 target price on the stock, down from their previous target price of $21.00.

The Ultimate Software Group (NASDAQ:ULTI) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $216.00 price target on the stock, down from their previous price target of $233.00.

The Ultimate Software Group (NASDAQ:ULTI) had its buy rating reaffirmed by analysts at Canaccord Genuity. The firm currently has a $225.00 target price on the stock, down from their previous target price of $240.00.

Vale (NYSE:VALE) was given a $8.00 price target by analysts at BMO Capital Markets. The firm currently has a hold rating on the stock.

Virtus Investment Partners (NASDAQ:VRTS) had its target price boosted by Credit Suisse Group from $141.00 to $147.00. They currently have a neutral rating on the stock. The analysts wrote, “attractive”

Wintrust Financial Corporation (NASDAQ:WTFC) had its market perform rating reiterated by analysts at Hovde Group. The firm currently has a $80.00 target price on the stock, up from their previous target price of $76.50.

Receive News & Ratings for Agios Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agios Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.